Navidea Biopharmaceuticals, Inc. (NAVB)
NYSEAMERICAN: NAVB · IEX Real-Time Price · USD
0.0920
+0.0018 (2.00%)
May 31, 2023, 4:00 PM EDT - Market closed
NAVB Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NAVB stock.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for NAVB.
Recommendation Trends
| Rating | Apr '20 | May '20 | Jun '20 | Jul '20 | Aug '20 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 |
Financial Forecast
Revenue This Year
n/a
from 65.65K
Revenue Next Year
n/a
EPS This Year
n/a
from -0.56
EPS Next Year
n/a
| Year | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1.17M | 657.83K | 915.01K | 531.51K | 65.65K |
| Revenue Growth | -35.41% | -43.74% | 39.10% | -41.91% | -87.65% |
| EPS | -1.89 | -0.76 | -0.48 | -0.40 | -0.56 |
| EPS Growth | - | - | - | - | - |
| No. Analysts | - | - | - | - | - |
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.